Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus, a Retrospective Chart Review
Phase of Trial: Phase IV
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 08 Feb 2017 Status changed from active, no longer recruiting to completed.
- 05 Jun 2012 Planned end date changed from 1 Jun 2011 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 24 Feb 2011 New trial record